vs
Nutex Health, Inc.（NUTX）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Nutex Health, Inc.的季度营收约是Resolute Holdings Management, Inc.的1.3倍（$151.7M vs $117.7M），Nutex Health, Inc.净利率更高（7.8% vs -1.5%，领先9.3%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $69.0M）
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
NUTX vs RHLD — 直观对比
营收规模更大
NUTX
是对方的1.3倍
$117.7M
净利率更高
NUTX
高出9.3%
-1.5%
自由现金流更多
RHLD
多$120.2M
$69.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $117.7M |
| 净利润 | $11.8M | $-1.7M |
| 毛利率 | 30.4% | 55.7% |
| 营业利润率 | 20.4% | 30.2% |
| 净利率 | 7.8% | -1.5% |
| 营收同比 | -41.1% | — |
| 净利润同比 | -80.8% | — |
| 每股收益（稀释后） | $2.34 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUTXRHLD
| Q4 25 | $151.7M | $117.7M | ||
| Q3 25 | $267.8M | $120.9M | ||
| Q2 25 | $244.0M | $119.6M | ||
| Q1 25 | $211.8M | $103.9M | ||
| Q4 24 | $257.6M | — | ||
| Q3 24 | $78.8M | — | ||
| Q2 24 | $76.1M | — | ||
| Q1 24 | $67.5M | — |
净利润NUTXRHLD
| Q4 25 | $11.8M | $-1.7M | ||
| Q3 25 | $55.4M | $-231.0K | ||
| Q2 25 | $-17.7M | $-611.0K | ||
| Q1 25 | $21.2M | $-3.4M | ||
| Q4 24 | $61.6M | — | ||
| Q3 24 | $-8.8M | — | ||
| Q2 24 | $-364.0K | — | ||
| Q1 24 | $-364.0K | — |
毛利率NUTXRHLD
| Q4 25 | 30.4% | 55.7% | ||
| Q3 25 | 57.8% | 59.0% | ||
| Q2 25 | 51.2% | 57.5% | ||
| Q1 25 | 55.9% | 52.5% | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 15.1% | — |
营业利润率NUTXRHLD
| Q4 25 | 20.4% | 30.2% | ||
| Q3 25 | 48.7% | 34.3% | ||
| Q2 25 | 13.8% | 34.0% | ||
| Q1 25 | 38.1% | 24.7% | ||
| Q4 24 | 44.4% | — | ||
| Q3 24 | 12.3% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | 2.1% | — |
净利率NUTXRHLD
| Q4 25 | 7.8% | -1.5% | ||
| Q3 25 | 20.7% | -0.2% | ||
| Q2 25 | -7.3% | -0.5% | ||
| Q1 25 | 10.0% | -3.2% | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | -11.2% | — | ||
| Q2 24 | -0.5% | — | ||
| Q1 24 | -0.5% | — |
每股收益（稀释后）NUTXRHLD
| Q4 25 | $2.34 | $-0.20 | ||
| Q3 25 | $7.76 | $-0.03 | ||
| Q2 25 | $-2.95 | $-0.07 | ||
| Q1 25 | $3.33 | $-0.39 | ||
| Q4 24 | $11.56 | — | ||
| Q3 24 | $-1.72 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.08 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.6M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $329.4M | $6.5M |
| 总资产 | $918.5M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资NUTXRHLD
| Q4 25 | $185.6M | $205.5M | ||
| Q3 25 | $166.0M | $148.0M | ||
| Q2 25 | $96.7M | $99.9M | ||
| Q1 25 | $84.7M | $71.0M | ||
| Q4 24 | $40.6M | — | ||
| Q3 24 | $46.9M | — | ||
| Q2 24 | $40.8M | — | ||
| Q1 24 | $30.0M | — |
总债务NUTXRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NUTXRHLD
| Q4 25 | $329.4M | $6.5M | ||
| Q3 25 | $317.2M | $10.8M | ||
| Q2 25 | $235.3M | $9.6M | ||
| Q1 25 | $176.9M | $8.9M | ||
| Q4 24 | $132.4M | — | ||
| Q3 24 | $60.4M | — | ||
| Q2 24 | $62.7M | — | ||
| Q1 24 | $63.0M | — |
总资产NUTXRHLD
| Q4 25 | $918.5M | $333.4M | ||
| Q3 25 | $964.5M | $293.2M | ||
| Q2 25 | $841.0M | $253.3M | ||
| Q1 25 | $761.9M | $214.3M | ||
| Q4 24 | $655.3M | — | ||
| Q3 24 | $438.5M | — | ||
| Q2 24 | $422.4M | — | ||
| Q1 24 | $404.3M | — |
负债/权益比NUTXRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.4M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $69.0M | $189.2M |
| 自由现金流率自由现金流/营收 | 45.5% | 160.8% |
| 资本支出强度资本支出/营收 | 0.9% | 5.8% |
| 现金转化率经营现金流/净利润 | 5.95× | — |
| 过去12个月自由现金流最近4个季度 | $245.6M | $313.2M |
8季度趋势，按日历期对齐
经营现金流NUTXRHLD
| Q4 25 | $70.4M | $196.1M | ||
| Q3 25 | $99.5M | $59.6M | ||
| Q2 25 | $27.3M | $48.9M | ||
| Q1 25 | $51.0M | $18.4M | ||
| Q4 24 | $54.0K | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $13.3M | — | ||
| Q1 24 | $3.1M | — |
自由现金流NUTXRHLD
| Q4 25 | $69.0M | $189.2M | ||
| Q3 25 | $99.2M | $58.6M | ||
| Q2 25 | $26.5M | $47.5M | ||
| Q1 25 | $50.9M | $17.8M | ||
| Q4 24 | $-341.0K | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $12.7M | — | ||
| Q1 24 | $2.3M | — |
自由现金流率NUTXRHLD
| Q4 25 | 45.5% | 160.8% | ||
| Q3 25 | 37.0% | 48.5% | ||
| Q2 25 | 10.9% | 39.7% | ||
| Q1 25 | 24.0% | 17.1% | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.7% | — | ||
| Q1 24 | 3.4% | — |
资本支出强度NUTXRHLD
| Q4 25 | 0.9% | 5.8% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | 0.3% | 1.2% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 1.1% | — |
现金转化率NUTXRHLD
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
RHLD
暂无分部数据
